Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma
Clinical trial NCT05646082 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05646082
- Sponsor
- Imperial College London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2026-07-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.